In cancer treatment, developing ideal anticancer drug delivery systems to target tumor microenvironment by circumventing various physiological barriers still remains a daunting challenge. Here, in our work, a series of pH- and temperature-responsive nanogels based on poly(N-isopropylacrylamide-co-1-propene-2-3-dicarboxylate-co-2-acrylamido-2-methyl-1-propanesulfonate [poly(NIPAAm-IA-AMPS)] cross-linked by ethylene glycol dimethacrylate (EGDMA) were synthesized by random copolymerization. The molar ratio between monomer-comonomers-cross-linker was varied to fine-tune the optimum responsiveness of the nanogels. These optimized nanogels were further coupled to N,O-carboxymethyl chitosan (NOCC) stoichiometrically using EDC-NHS coupling chemistry to enhance the swelling behavior at lower pH. Interestingly, these NOCC-g-nanogels, when dispersed in aqueous media under sonication, attain nanosize and retain their high water-retention capacity with conspicuous pH and temperature responsiveness (viz. nanogel shrinkage in size beyond 35 °C and swelled at acidic pH) in vitro, as reflected by dynamic light scattering data. Doxorubicin (DOX), a potent anticancer drug, was loaded into these nanogels using the physical entrapment method. These drug-loaded nanogels exhibited a slow and sustained DOX release profile at physiological temperature and cytosolic pH. Furthermore, confocal and TEM results demonstrate that these nanogels were swiftly internalized by MCF-7 cells, and cell viability data showed preferential heightened cytotoxicity toward cancer cells (MCF-7 and MDA-MB231) compared to the MCF10A cells (human breast epithelial cell). Furthermore, intracellular DNA damage and cell cycle arrest assays suggest a mitochondrial mediated apoptosis in MCF-7 cells. This study substantiates our NOCC-g-nanogel platform as an excellent modality for passive diffusive loading and targeted release of entrapped drug(s) at physiological conditions in a controlled way for the improved therapeutic efficacy of the drug in anticancer treatment.
New N-octylated benzimidazole-based diamide ligands N,N'-bis(N-octylbenzimidazolyl-2-ethyl)hexanediamide (O-ABHA), possessing a chiral center, and N,N'-bis(N-octylbenzimidazolyl-2-methyl)hexanediamide (O-GBHA) have been synthesized and utilized to prepare Cu(II) complexes of general composition [Cu(L)X]X, where L = O-ABHA or O-GBHA and X = Cl(-) or NO(3)(-) . The X-ray structure of one of the complexes, [Cu(O-GBHA)NO(3)]NO(3), has been obtained. The Cu(II) ion is found to possess a distorted octahedral geometry with a highly unsymmetrical bidentate nitrate group. The N(2)O(2) equatorial plane comprises an amide carbonyl O, a nitrate O, and the two benzimidazole imine N atoms while another amide carbonyl O and nitrate O take up the axial positions. The complexes carry out the oxidation of aromatic alcohols to aldehydes in the presence of cumenyl hydroperoxide at 40-45 degrees C and act as catalyst with turnovers varying between 13- and 27-fold. The percentage yields of the respective products have been obtained which vary from 32% to 65% with respect to the catalyst turnover.
Oxidation O 0212 1-Methyl-3-butylimidazolium Decatungstate in Ionic Liquid: An Efficient Catalyst for the Oxidation of Alcohols. -The new [bmim]4[W10O23] is used as catalyst for the selective oxidation of benzylic and aliphatic secondary alcohols in ionic liquids. Primary aliphatic alcohols do not react. -(CHHIKARA, B. S.; TEHLAN, S.; KUMAR*, A.; Synlett 2005, 1, 63-66; Dep. Chem., Univ. Delhi, Delhi 110 007, India; Eng.) -S. Adam 22-044
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.